Contributions Help Fund Ongoing Research, Facilities and Family Support
ATLANTA, March 19 /PRNewswire/ -- In its ongoing support of the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta, Aflac announced that it has reached more than $40 million in contributions to the Center, making it the largest corporate supporter of Children's Healthcare of Atlanta.
"With financial resources provided by Aflac, we have been able to recruit national leaders in the fields of pediatric cancer, sickle cell disease and experimental therapy and have also established a thriving program for cancer survivors," said William G. Woods, M.D., director for the Aflac Cancer Center. "These leaders are conducting important lab and clinical research and helping to bring innovative treatments to patients at the bedside - not just in Georgia, but nationwide."
Thousands of Aflac field force members across the country and the Aflac
Foundation together have funded four endowed chairs at the Aflac Cancer
Center, each of which provides critical funding in perpetuity for key
positions at the Center. At Children's Healthcare of Atlanta, receiving a
chair signifies a monetary endowment for a specific program directed by a
physician or researcher. To date, Aflac has funded the following chairs:
-- Dr. William G. Woods - The Daniel P. Amos Children's Chair for the
Aflac Cancer Center and Blood Disorders Service
-- Dr. Donald Durden - The Aflac Field Force Cancer Experimental Therapy
-- Dr. Lillian R. Meacham - The Kathelen V. Amos Children's Chair for
-- Dr. Peter Lane - The Aflac Field Force Children's Chair for Sickle Cell
Over the years, Aflac's contributions have also been used to fund other
critical needs, including new inpatient and outpatient facilities, a new
state-of-the-art pediatric resea
Copyright©2008 PR Newswire.
All rights reserved